Alpine Global Management, LLC Novo Cure LTD Transaction History

Alpine Global Management, LLC

  • $265 Million
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022
SELL
$60.15 - $84.52 $618,642 - $869,288
-10,285 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$75.08 - $121.99 $772,197 - $1.25 Million
10,285 New
10,285 $772,000
Q4 2019

Jan 16, 2020
SELL
$68.3 - $93.8 $258,788 - $355,408
-3,789 Closed
0 $0
Q3 2019

Oct 11, 2019
BUY
$61.86 - $97.8 $234,387 - $370,564
3,789 New
3,789 $283,000

Others Institutions Holding NVCR

# of Institutions
289
Shares Held
75.6M
Call Options Held
1.77M
Put Options Held
538K
View Full List

About NovoCure Ltd

NVCR Quotes by TradingView
  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $2.29B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Alpine Global Management, LLC Portfolio

Follow Alpine Global Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpine Global Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email